A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease - Wikidata - awgldk - TriplyDB

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease

http://www.wikidata.org/entity/Q35132279

about

Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View Long-term Outcomes of Childhood Onset Nephrotic Syndrome FSGS: Diagnosis and Diagnostic Work-Up Recurrence and Treatment after Renal Transplantation in Children with FSGS Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues Nephrotic syndrome: what's new, what's hot?Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy.Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.Soluble Urokinase Receptor and Chronic Kidney Disease.Drug discovery in focal and segmental glomerulosclerosis Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study Unwinding focal segmental glomerulosclerosis Markers of disease and steroid responsiveness in paediatric idiopathic nephrotic syndrome: Whole-transcriptome sequencing of peripheral blood mononuclear cells.Focal segmental glomerular sclerosis: do not overlook the role of immune response.Extrarenal determinants of kidney filter function.Current status of pediatric renal transplant pathology.Focal Segmental Glomerulosclerosis.Podocyte-actin dynamics in health and disease.Minimal change disease and idiopathic FSGS: manifestations of the same disease.Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome.suPAR and chronic kidney disease-a podocyte story.Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease.Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.Reassessing the Reassessment of suPAR in Glomerular Disease.Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.What Are the Newer Applications for Therapeutic Apheresis in Nephrology?: What Is on the Horizon for Therapeutic Apheresis Medicine in Nephrology?Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.The intriguing role of soluble urokinase receptor in inflammatory diseases.Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.A bone marrow factor contributes to kidney disease.Con: Biomarkers in glomerular diseases: putting the cart before the wheel?NephCure Accelerating Cures Institute: A Multidisciplinary Consortium to Improve Care for Nephrotic Syndrome.Experimental concerns regarding suPAR-related proteinuria

P2860

Q26738374-ABA9431C-172E-4C8F-BD49-F5A50CCFE4CB Q26744025-4F19112C-DD53-473B-896E-AAAA39BFB91A Q26744558-0F1AEE21-0DE7-4E90-AAE4-81269869DC25 Q26746985-783500CA-37D2-4E20-80E5-B74C4F9EA36B Q26747221-C01981E1-9AE1-4A4A-A632-DD197B818BF9 Q26776389-1312B9E4-5C0B-4482-9E97-0272756EA01C Q26782879-37667F04-C4D8-4D55-B094-D72844ACA046 Q26799177-945FBF05-00FA-4DE3-9F0B-53C125A04F13 Q33605113-715D9F36-D1E2-4CE0-B7B0-788B07069636 Q35689353-ACBB0CE5-EA1A-427A-8686-1CB981B8FD03 Q35779133-683B6A29-AEB0-4DB2-BD6D-A4650A12A891 Q36429637-150B229A-960C-463D-9123-FE5D315FEA94 Q36924116-AA6676A2-BF37-4BD5-9889-70A50CCC679B Q36992978-CB873F7C-03EC-48F3-9D87-A57003062B31 Q38685434-E84056E8-43AD-47C7-9814-39C2734C01EA Q38714386-E39BC55F-BFE0-4EEC-8917-95F7297B45CC Q38742004-0CB87711-18A5-4A74-8F27-2845A81A720F Q38754939-951B08C3-1331-47CC-842F-6D3E76FABE6B Q38843499-428FE4EC-8274-4D09-98C3-FA4CFF2BB815 Q38938623-2106E2FC-4A50-4068-AC58-B7905246AB58 Q38940494-3ABCDE94-8B41-4082-A6DA-7DFC29472CF7 Q38982416-743FA259-4C24-4607-9A7B-6533149FCD61 Q39335899-A934C50F-DF74-4FDC-AC60-FF76BB8BE522 Q39423366-BCD3F129-063D-473E-9A8E-530A3ED954E8 Q40216229-5B28866D-CBA6-4F4B-BEFB-78755C783BAF Q41688065-5EF96DD1-E6E4-4E50-9CAF-A49B0FFF6F48 Q42361928-A4C98C08-81D9-4E19-B3CD-544FDD03A076 Q42365618-BACFD78A-BF37-4B53-AADF-FDE2498D4B52 Q43105950-D0003CCE-FE3F-421A-9F19-F69EE8143FD5 Q43239317-2D4E79E3-DF83-4958-8A7E-1D4E0C0AF027 Q44256854-BF848502-AED1-4C79-9A5E-DE463E8E6BE1 Q46185078-E6B2DF5E-48C6-4ADC-B739-7081458636BD Q47854753-753CA58A-977F-4B25-8770-B47BA5A01B1D Q49124480-725E9678-4C17-439A-BE32-D5D721172312 Q52573827-A3BBC929-D4E7-4460-A713-61015588565E Q52715295-704B4FC0-D263-466E-9873-386B9BE27D27 Q52805946-E6D25BBC-6F59-4EE4-8758-BAB631BA61C4 Q53497916-FC6D3912-22B1-427A-BC00-274DC42C8190 Q55371699-ABC5DE0E-EE45-4FDE-82D0-52C81499F2E1 Q57726936-2B308476-6026-4F99-9F65-54C91F658748

P2860

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease

http://www.wikidata.org/entity/Q35132279

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A reassessment of soluble urok ...... receptor in glomerular disease

@ast

A reassessment of soluble urok ...... receptor in glomerular disease

@en

type

label

A reassessment of soluble urok ...... receptor in glomerular disease

@ast

A reassessment of soluble urok ...... receptor in glomerular disease

@en

prefLabel

A reassessment of soluble urok ...... receptor in glomerular disease

@ast

A reassessment of soluble urok ...... receptor in glomerular disease

@en

P1433

Q35132279-69B7BBEE-6C84-4C78-BDB3-9E0A73BBF87F

P1476

Q35132279-EAD929B2-FC2D-41D0-A0E3-FA3DB5FE6331

P2093

Q35132279-0AE0450B-3BCF-4231-A8E4-723E99677D78

Q35132279-378010E5-7832-42B0-8F9F-F7ED4D2301BE

Q35132279-3D549037-0B17-4B4A-87C7-CF2A2DD0EE24

Q35132279-655E4D3A-6D8D-47D5-B9FE-B8CF4C86CA74

Q35132279-7C870B54-4847-44F8-86E0-6EE8EB659322

Q35132279-8D31D6DF-AF5D-477E-B1ED-16C096CE1BB3

Q35132279-A7EFAB56-642F-4911-8DD8-DFFFEDFC3847

Q35132279-C8E7B2A2-B5B9-4053-9344-9A21F292DC49

Q35132279-D4C8C1B9-CEC1-4EA6-AEB8-57B7EE0C42E3

Q35132279-DA48C733-7E61-4C8D-B5A9-7D09F12BFA0D

P2860

Q35132279-0D4EC142-3891-4906-86DD-0A3273533CB9

Q35132279-0E16E057-C0C5-4443-BDBB-E48A78488B25

Q35132279-1349EB71-AAC8-4F2F-8D6F-42A447A29759

Q35132279-13CF12D9-0BF1-4771-9CFA-475988DE4D88

Q35132279-1CE774C4-1AD9-49D7-84BE-60E18DF8C561

Q35132279-26D885D2-C199-428B-9881-D0203884920D

Q35132279-3189F230-00AB-4551-89BC-8E694DC48252

Q35132279-37AD8C42-6509-4874-886F-7809A085B0C9

Q35132279-4E532B8C-FF4E-4EA9-B659-1BD4AEF35BEE

Q35132279-5E86ADCD-FCEF-408C-BB02-EA470B9CF884

P2888

Q35132279-5C1A0798-BC76-4A0A-B6C6-0C683F514013

P304

Q35132279-96069872-B8DD-4DE7-A68D-9AEFFD7232DE

P31

Q35132279-34C8464C-CB78-4DA2-9CC0-4BF3653A1B77

P356

Q35132279-CA3C524F-F1D3-47FB-82E9-0767B7E78C1E

P407

Q35132279-7A1B7543-B997-44CE-B40E-E85111DE7E08

P433

Q35132279-609C9DE8-CFD7-42A6-8928-1C6AE4406279

P478

Q35132279-B4B9E555-14DB-4D92-A6EE-E861CB8646F5

P50

Q35132279-E765DF28-A93C-4F59-9517-70F8C831E6CC

P577

Q35132279-903511B4-F1CA-4250-852B-DCD0B275EB49

P5875

Q35132279-7E3AFC37-C8BD-4069-A8D6-DDE2616557A1

P6179

Q35132279-629F441D-CE34-4C25-BA0A-DEDDD4601295

P698

Q35132279-0171B59D-7AE8-4DCC-94F5-BDA8DEDBEAC5

P932

Q35132279-6AE094B8-5BDD-475D-B84D-EC49BC64C3EA

P356

P1433

Kidney International

P1476

A reassessment of soluble urok ...... receptor in glomerular disease

@en

P2093

Crystal A Gadegbeku

http://www.w3.org/2001/XMLSchema#string

Deepak Nihalani

http://www.w3.org/2001/XMLSchema#string

Hetty N Wong

http://www.w3.org/2001/XMLSchema#string

Jidong Zhang

http://www.w3.org/2001/XMLSchema#string

Joann M Spinale

http://www.w3.org/2001/XMLSchema#string

Jonathan P Troost

http://www.w3.org/2001/XMLSchema#string

Laura H Mariani

http://www.w3.org/2001/XMLSchema#string

Lawrence B Holzman

http://www.w3.org/2001/XMLSchema#string

Matthias Kretzler

http://www.w3.org/2001/XMLSchema#string

Nephrotic Syndrome Study Network

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated encyclopedia of DNA elements in the human genome

Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

New equations to estimate GFR in children with CKD

A new equation to estimate glomerular filtration rate

suPAR: the molecular crystal ball

A global double-fluorescent Cre reporter mouse

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates

Circulating suPAR in two cohorts of primary FSGS.

P2888

P304

564-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2014.346

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Debbie S Gipson

P577

2014-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267738445

http://www.w3.org/2001/XMLSchema#string

P6179

1043258935

http://www.w3.org/2001/XMLSchema#string

P698

25354239

http://www.w3.org/2001/XMLSchema#string

P932

4344842

http://www.w3.org/2001/XMLSchema#string